RRM2 and liver cancer: By testing 30 normal liver and 40 liver cancer tissue specimens using tissue microarray assay (TMA), RRM2 was further confirmed to be significantly upregulated in liver cancer compared to normal liver (Fig. 1e), which is supported by the data from the UALCAN database (http://ualcan.path.uab.edu) (Fig. 1f).